The Use of Contrast-Enhancement Cardiovascular Magnetic Resonance Imaging in Cardiomyopathies

The clinical applications of cardiovascular magnetic resonance imaging (CMR), are expanding as the result of the development in hardware, pulse sequence and the ability of post-processing techniques. As the result of the flexibility of CMR to use different pulsesequences, with or without the use of Gadolinium, CMR has developed as a powerful tool for clinical relevant tissue characterization. CMR in combination with the contrastenhancement (CE) technique was initially developed to distinguish viable from non-viable myocardium following myocardial infarction. Nowadays, CE-CMR is increasingly used for tissue characterization in ischemic as well as non-ischemic cardiomyopathies to determine the exact etiology, guide proper treatment, and predict outcome and prognosis. In this chapter, we would like to discuss and illustrate the value of CE-CMR imaging in various cardiomyopathies.

[1]  R. Esper.  Cardiomyopathies: From Basic Research to Clinical Management , 2013 .

[2]  A. van Rossum,et al.  The development of familial hypertrophic cardiomyopathy: from mutation to bedside , 2011, European journal of clinical investigation.

[3]  B. Maron,et al.  Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature. , 2011, Journal of the American College of Cardiology.

[4]  N. Kløw,et al.  Takotsubo cardiomyopathy in acute coronary syndrome; clinical features and contribution of cardiac magnetic resonance during the acute and convalescent phase , 2011, Scandinavian cardiovascular journal : SCJ.

[5]  C. von Birgelen,et al.  Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability , 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[6]  Douglas P. Zipes,et al.  Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition , 2011 .

[7]  Ingo Eitel,et al.  T2-weighted cardiovascular magnetic resonance in acute cardiac disease , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[8]  J. van der Palen,et al.  Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast enhancement cardiovascular magnetic resonance imaging study , 2011, Journal of Cardiovascular Magnetic Resonance.

[9]  James A. White,et al.  Delayed enhancement cardiac magnetic resonance imaging predicts future arrhythmic events in primary prevention ICD candidates irrespective of ischemic or non-ischemic etiology , 2011, Journal of Cardiovascular Magnetic Resonance.

[10]  Jan A Staessen,et al.  Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.

[11]  M. Stoel,et al.  Early versus late ST-segment resolution and clinical outcomes after percutaneous coronary intervention for acute myocardial infarction , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[12]  F. Van de Werf,et al.  Myocardial salvage by CMR correlates with LV remodeling and early ST-segment resolution in acute myocardial infarction. , 2010, JACC. Cardiovascular imaging.

[13]  W. Hundley,et al.  Novel Approach to Early Detection of Doxorubicin Cardiotoxicity by Gadolinium-Enhanced Cardiovascular Magnetic Resonance Imaging in an Experimental Model , 2010, Circulation. Cardiovascular imaging.

[14]  F. H. Man,et al.  Thrombus aspiration in a series of patients with stable or unstable angina pectoris and lesion-site thrombus formation , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[15]  M. Schieber,et al.  Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.

[16]  Gilbert Habib,et al.  Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. , 2010, European heart journal.

[17]  H. Oflaz,et al.  MR imaging features of ventricular noncompaction: emphasis on distribution and pattern of fibrosis. , 2010, European journal of radiology.

[18]  C. Lücke,et al.  Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging , 2010, European Radiology.

[19]  A. Tajik,et al.  Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.

[20]  M. Schaller,et al.  Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  R. Kim,et al.  Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.

[22]  M. Link,et al.  Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease. , 2009, Circulation.

[23]  J. W. Louwerenburg,et al.  Primary percutaneous coronary intervention in the left main stem of a monocoronary artery , 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[24]  F. Carreras,et al.  Transient Left Ventricular Basal Ballooning–“Inverted” Tako‐tsubo , 2009, Clinical cardiology.

[25]  E. Yeh,et al.  Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. , 2009, Journal of the American College of Cardiology.

[26]  Ai-Hsien Li,et al.  Cardiac magnetic resonance imaging in sunitinib malate-related cardiomyopathy: no late gadolinium enhancement. , 2009, Journal of the Chinese Medical Association : JCMA.

[27]  Carmel Hayes,et al.  Assessment of Myocardial Viability with 3D MRI at 3 T. , 2009, AJR. American journal of roentgenology.

[28]  M. Stoel,et al.  Aspiration of embolized thrombus during primary percutaneous coronary intervention , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[29]  Katja Zeppenfeld,et al.  Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.

[30]  M. Yokokawa,et al.  Nontransmural Scar Detected by Magnetic Resonance Imaging and Origin of Ventricular Tachycardia in Structural Heart Disease , 2009, Pacing and clinical electrophysiology : PACE.

[31]  M. Yokokawa,et al.  The Characteristics and Distribution of the Scar Tissue Predict Ventricular Tachycardia in Patients with Advanced Heart Failure , 2009, Pacing and clinical electrophysiology : PACE.

[32]  D. Pennell,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Cardiovascular Magnetic Resonance and Prognosis in Cardiac Amyloidosis , 2022 .

[33]  G. Thiene,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Cardiac Involvement in Patients with Becker Muscular Dystrophy: New Diagnostic and Pathophysiological Insights by a Cmr Approach , 2022 .

[34]  U. Reiter,et al.  The Emerging Role of Magnetic Resonance Imaging in the Diagnosis and Management of Pulmonary Hypertension , 2008, Respiration.

[35]  G. Layer,et al.  Clinical, angiographic and cardiovascular magnetic resonance findings in consecutive patients with Takotsubo cardiomyopathy , 2008, Clinical Research in Cardiology.

[36]  P. Algra,et al.  Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. , 2008, Journal of the American College of Cardiology.

[37]  A. Attili,et al.  Cardiomyopathy: magnetic resonance imaging evaluation. , 2008, Seminars in roentgenology.

[38]  S. Feuerbach,et al.  Time course of eosinophilic myocarditis visualized by CMR , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[39]  J. Schulz-Menger,et al.  Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[40]  J. Schulz-Menger,et al.  Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease , 2008, The International Journal of Cardiovascular Imaging.

[41]  M. Gutberlet,et al.  Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. , 2008, Radiology.

[42]  R. Cury,et al.  Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: correlation with clinical severity. , 2007, AJR. American journal of roentgenology.

[43]  E. McVeigh,et al.  T2‐prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo , 2007, Magnetic resonance in medicine.

[44]  N. Bellenger,et al.  Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement. , 2007, Clinical radiology.

[45]  Eike Nagel,et al.  Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. , 2007, The American journal of cardiology.

[46]  R. Nijveldt,et al.  Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease. , 2007, Heart, lung & circulation.

[47]  C. Rochitte,et al.  Cardiac magnetic resonance in Chagas' disease. , 2007, Artificial organs.

[48]  Jan Bogaert,et al.  Value of MRI in patients with a clinical suspicion of acute myocarditis , 2007, European Radiology.

[49]  Ali Yilmaz,et al.  Significance of Late Gadolinium Enhancement in Cardiovascular Magnetic Resonance Imaging (CMR) , 2007, Herz Kardiovaskuläre Erkrankungen.

[50]  F. Crea,et al.  Letter by Pieroni et al regarding article, "Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy". , 2007, Circulation.

[51]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[52]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[53]  A. van Rossum,et al.  Clinical applications of cardiovascular magnetic resonance imaging , 2006, Canadian Medical Association Journal.

[54]  T. Yasu,et al.  Transient mid-ventricular ballooning cardiomyopathy: a new entity of Takotsubo cardiomyopathy. , 2006, International journal of cardiology.

[55]  Katherine C. Wu,et al.  Delayed enhancement MR imaging: utility in myocardial assessment. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[56]  P. Kellman,et al.  Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm , 2006, Journal of magnetic resonance imaging : JMRI.

[57]  C. Kramer,et al.  The evolving role of cardiovascular magnetic resonance imaging in nonischemic cardiomyopathy. , 2006, Seminars in ultrasound, CT, and MR.

[58]  Katherine C. Wu,et al.  MRI assessment of myocardial viability. , 2006, Seminars in ultrasound, CT, and MR.

[59]  J. Lima,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.

[60]  J. Foster,et al.  Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. , 2005, European heart journal.

[61]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[62]  Raymond J Kim,et al.  Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. , 2005, Journal of the American College of Cardiology.

[63]  Robert R Edelman,et al.  Contrast-enhanced MR imaging of the heart: overview of the literature. , 2004, Radiology.

[64]  K. Klingel,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[65]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[66]  Elliot R. McVeigh,et al.  Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells , 2003, Circulation.

[67]  Jérôme Garot,et al.  Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. , 2003, Journal of the American College of Cardiology.

[68]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[69]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[70]  D. Kraitchman,et al.  Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. , 2003, Journal of the American College of Cardiology.

[71]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[72]  W. McKenna,et al.  Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance , 2002, European journal of heart failure.

[73]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[74]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[75]  E. Wigle,et al.  The diagnosis of hypertrophic cardiomyopathy , 2001 .

[76]  J. Schulz-Menger,et al.  Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. , 2001, American heart journal.

[77]  R. Maruyama,et al.  Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. , 2001, The American journal of medicine.

[78]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[79]  A. Devlin,et al.  Diagnosis of hypertrophic cardiomyopathy and screening for the phenotype suggestive of gene carriage in familial disease: a simple echocardiographic procedure , 2000, Journal of medical screening.

[80]  N. Ohkubo,et al.  [Gadolinium-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging of dilated cardiomyopathy: clinical significance of abnormally high signal intensity of left ventricular myocardium]. , 1996, Journal of cardiology.

[81]  G. Thiene,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[82]  Richard J. Jones.  Heart Disease: A Textbook of Cardiovascular Medicine , 1980 .

[83]  Randall J. Lee,et al.  Stem Cells for Myocardial Regeneration , 2010, Methods in Molecular Biology.

[84]  C. Hamm,et al.  Value of gadolinium-enhanced magnetic resonance imaging in patients with Tako-Tsubo-like left ventricular dysfunction. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[85]  S. Mavrogeni,et al.  Magnetic Resonance Imaging in the Evaluation of , 2005 .

[86]  E. D. Wigle,et al.  Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy , 2003 .

[87]  D. Pennell,et al.  Images in cardiovascular Medicine. Magnetic resonance contrast enhancement of iatrogenic septal myocardial infarction in hypertrophic cardiomyopathy. , 2002, Circulation.

[88]  R. Geuns,et al.  Images in Cardiovascular Medicine , 2000 .